在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

CLCN7 Antibody

  • 中文名稱:
    CLCN7兔多克隆抗體
  • 貨號:
    CSB-PA005486ESR1HU
  • 規(guī)格:
    ¥440
  • 圖片:
    • Immunohistochemistry of paraffin-embedded human colon cancer using CSB-PA005486ESR1HU at dilution of 1:100
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品名稱:
    Rabbit anti-Homo sapiens (Human) CLCN7 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
    CLCN7
  • 別名:
    Chloride channel protein 7 antibody; CLC 7 antibody; ClC-7 antibody; ClC7 antibody; CLCN7 antibody; CLCN7_HUMAN antibody; FLJ26686 antibody; FLJ39644 antibody; FLJ46423 antibody; H(+)/Cl(-) exchange transporter 7 antibody; OPTA2 antibody; OPTB4 antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human
  • 免疫原:
    Recombinant Human H(+)/Cl(-) exchange transporter 7 protein (626-805AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標(biāo)記方式:
    Non-conjugated
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    Antigen Affinity Purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA, IHC
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:20-1:200
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

  • 功能:
    Slowly voltage-gated channel mediating the exchange of chloride ions against protons. Functions as antiporter and contributes to the acidification of the lysosome lumen and may be involved in maintaining lysosomal pH. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons. The presence of conserved gating glutamate residues is typical for family members that function as antiporters.
  • 基因功能參考文獻:
    1. In this study, whole exome sequencing (WES) was successfully used in six patients with malignant infantile osteopetrosis (MIOP) and identified mutations in four MIOP-related genes (CLCN7, TCIRG1, SNX10, and TNFRSF11A). PMID: 27187610
    2. The present study revealed three novel mutations, showed the dense but brittle sclerotic bones of an autosomal dominant osteopetrosis type II (OPTA2) patient, characterized OPTA2 symptoms from benign to fatal and reported a rare intermediate case of autosomal recessive 4 in a Chinese population. PMID: 28975865
    3. we identified a CLCN7 mutation in a family with autosomal dominant osteopetrosis, RTA, renal stones, epilepsy, and blindness. PMID: 27540713
    4. present findings suggest that the novel missense mutations V289L and A542V in the CLCN7 gene were responsible for autosomal dominant osteopetrosis (type II) in the two Chinese families. PMID: 26056022
    5. Exome sequencing and Sanger sequencing were conducted in Han Chinese family members, some of whom had typical osteopetrosis, and a novel missense variant c.2350A>T (p.R784W) in the chloride channel 7 gene (CLCN7) was identified. PMID: 27325559
    6. The present study identified seven novel mutations of the CLCN7 gene and reported the first case of intermediate autosomal recessive osteopetrosis. with compound heterozygous mutation in the Chinese population. PMID: 26395888
    7. study demonstrates a wide heterogeneity in the progression of the phenotypes and expanded the mutational spectrum for the CLCN7 gene PMID: 26477479
    8. the unusual clinical presentation observed in our patient with a mild clinical onset evolving towards a more serious clinical picture, is associated to two novel mutations on CLCN7 gene. PMID: 25410126
    9. Results show that ClC-7 is strongly expressed in OUMS-27,a chondrocyte cell line and is responsible for Cl- current. Its downregulation during the hypoosmotic stress accompanying osteoarthritis progression is part of the complex etiology of the disease. PMID: 25943117
    10. analysis demonstrates that CLCN7 and TCIRG1 mutations differentially affect bone matrix mineralization, and that there is a need to modify the current classification of osteopetrosis PMID: 24108692
    11. recurrent p.Gly215Arg mutation and novel missense mutations p.Ala299Val and p.Trp319Arg in the CLCN7 gene were responsible for these three Chinese ADO-II families. PMID: 23953223
    12. ClC-7 does not appear to be crucially involved in gastric acid secretion, which explains the absence of an osteopetrorickets phenotype in CLCN7-related osteopetrosis. PMID: 24103576
    13. Eight mutations, including two reported mutations (R767W and E798FS) and six novel mutations (E313K, A316G, R743W, G741R, W127G and S290F), were detected in the CLCN7 gene from 12 living autosomal dominant osteopetrosis type II patients. PMID: 21947783
    14. The authors show that both the aminoterminus and transmembrane span of the Ostm1 beta-subunit are required for ClC-7 Cl(-)/H(+)-exchange, whereas the Ostm1 transmembrane domain suffices for its ClC-7-dependent trafficking to lysosomes. PMID: 21527911
    15. Rat G213R ClC-7 is the analogue of human G215R ClC-7 responsible for autosomal dominant osteopetrosis type II. PMID: 20830208
    16. Elevated serum LDH isoenzymes and AST indicate a disturbance (of uncertain clinical significance) within multiple extraosseous tissues when there is CLCN7 deficiency. PMID: 20499337
    17. We report on the fatal clinical course of a 3 year old male Turkish patient suffering from osteopetrosis caused by a homozygous mutation in the chloride channel gene ClCN7 with developing pancytopenia and severe neurological impairment. PMID: 19904698
    18. That the CLCN7 mutations provoke a phenotype as severe as the one caused by TCIRG1 loss of function suggests the affected residues to be crucial for the function of the ClC-7 chloride channel or chloride/proton-exchanger PMID: 20424301
    19. The characterization of 25 unpublished patients has resulted in the identification of 20 novel mutations, including 11 missense mutations, 6 causing premature termination, 1 small deletion and 2 putative splice site defects and clinical heterogeneity. PMID: 19953639
    20. clcn7 gene mutation is associated with intermediate autosomal recessive osteopetrosis PMID: 12522560
    21. mutations in the CICN7 gene are responsible for autosomal dominant osteopetrosis, type II, an uncommon sclerosing bone disorder PMID: 12929941
    22. ClCN7 mutations have roles in severe recessive, dominant, and intermediate osteopetrosis PMID: 14584882
    23. ClC-7 has a role in causing autosomal dominant osteopetrosis type II PMID: 15111300
    24. The study indicates that the V418M polymorphism of CLCN7 contributes to the genetic regulation of femoral neck BMD in women. PMID: 16234969
    25. Significant association of CLCN7 polymorphisms with the variance of bone density in postmenopausal women with osteopetrosis. PMID: 16368748
    26. Autosomal dominant osteopetrosis caused by mutations in the CLCN7 gene is a frequently symptomatic disease manifested by a high rate of fracture, osteomyelitis, visual loss, and occasional bone marrow failure. PMID: 17164308
    27. ClC-7 is a Cl-/H+ antiporter; it constitutes the major Cl- permeability of lysosomes, and it is important in lysosomal acidification. PMID: 18449189
    28. Genetic variation in the CLCN7 gene is not a major contributor to the variability in peak BMD at the femoral neck and lumber spine in healthy premenopausal white women and in white men PMID: 18755304
    29. These data demonstrate that ClC-7 is essential for bone resorption, via its role in acidification of the lysosomes and resorption lacunae in osteoclasts PMID: 19070589
    30. Findings suggest that the novel Glu798FS mutation in exon 25 and R767W in exon 24 in the CLCN7 gene were responsible for autosomal dominant osteopetrosis (type II) in two Chinese patients. PMID: 19288050
    31. Mutations in TCIRG1, OSTM1, ClCN7, and TNFRSF11A genes were detected in nine, three, one, and one patientswith infantile malignant osteopetrosis, respectively. PMID: 19507210
    32. results suggest that osteoclastic ClC7 Cl(-) channels are activated under extracellar acidification and suppressed in Clcn7 mutant associated with autosomal osteopetrosis type II during bone resorption. PMID: 19543743

    顯示更多

    收起更多

  • 相關(guān)疾?。?/div>
    Osteopetrosis, autosomal recessive 4 (OPTB4); Osteopetrosis, autosomal dominant 2 (OPTA2); Osteopetrosis, autosomal recessive 2 (OPTB2)
  • 亞細胞定位:
    Lysosome membrane; Multi-pass membrane protein.
  • 蛋白家族:
    Chloride channel (TC 2.A.49) family, ClC-7/CLCN7 subfamily
  • 組織特異性:
    Brain and kidney.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 2025

    OMIM: 166600

    KEGG: hsa:1186

    STRING: 9606.ENSP00000372193

    UniGene: Hs.459649



主站蜘蛛池模板: 亚洲精品国产精华液| 欧美一区二区三区久久综| 暴力强奷在线播放无码| 东京热久久综合久久88| 18禁黄无遮挡网站| 国产手机在线国内精品| 国产精品自在自线视频| 国产农村黄aaaaa特黄av毛片| 亚洲人精品亚洲人成在线| 大陆国语对白国产av片| 久久久久有精品国产麻豆| 久久五十路丰满熟女中出| 国产饥渴孕妇在线播放| 天堂中文在线最新版地址| 国产特级毛片aaaaaaa高清| 蜜臀av色欲a片无码精品一区| 又色又爽又黄的吃奶视频免费观看 | 久久天天躁狠狠躁夜夜96流白浆 | 在线看片免费人成视频国产片| 亚洲精品久久久久中文字幕二区| 99噜噜噜在线播放| 韩国精品一区二区三区四区| 成人亚洲精品久久99狠狠| 久久午夜无码鲁丝片直播午夜精品| 少妇的肉体在线观看| 四虎国产成人永久精品免费| av无码国产在线观看岛国| 无码日韩人妻av一区免费| 国产真实老熟女无套内射| 香蕉av福利精品导航| 亚洲精品你懂的在线观看| 国产肉丝袜在线观看| 精品综合久久久久久98| 男女啪祼交视频| 99久久无码一区人妻a黑| 免费国产黄线在线观看| 高潮毛片无遮挡高清免费 | 亚洲香蕉成人av网站在线观看| 亚洲第一极品精品无码| 18岁日韩内射颜射午夜久久成人| 中文字幕人乱码中文|